Welcome to the CRESCENT™ Interactive Case Study Series
56-Year-Old Hispanic Female With CKD Secondary to Diabetes Mellitus Type II
This educational activity is sponsored by The France Foundation, and is supported by an educational donation provided by Amgen.
CRESCENT CME Interactive Case Reviewers
David A. Bushinsky, MD «Click here for bio»
David M. Spiegel, MD «Click here for bio»
It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty involved in this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a faculty member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity.
David A. Bushinsky, MD, has served as a speaker and consultant for Shire Pharmaceuticals Group and Amgen, and has performed clinical studies for Genzyme. He owns stock in Amgen.
David M. Spiegel, MD, has received speaking honoraria from Abbott Laboratories, Amgen, and Genzyme. He is a member of the advisory panel for Amgen and has received grant support from Abbott Laboratories and Amgen.
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and Amgen assume no liability for the information herein.
Chronic kidney disease (CKD) affects 8.3 million people in the United States. According to the National Kidney Foundation (NKF), 700,000 patients with CKD suffer from severely reduced kidney function or end-stage kidney failure. Many of these patients suffer from disorders of bone and mineral metabolism, including secondary hyperparathyroidism (sHPT), disorders of calcium and phosphorus metabolism, and soft tissue and vascular calcification. Alarmingly, the NKF predicts the number of patients with sHPT will double by 2010.
Recent research has identified new approaches for managing the progression of sHPT. This educational initiative will discuss therapeutic options for sHPT, and provide forums to critically analyze the latest information with leaders in the field. These interactive sessions will consist of presentations and discussion intended to help nephrologists and other health care practitioners to better manage their patients with CKD and improve patient outcomes.
CKD, with the frequent complication of sHPT, thus represents a major medical problem in the US. Recent research has identified new approaches for managing the progression of sHPT. The CRESCENT initiative will present these new findings to physicians and other health care practitioners who care for patients with CKD. This educational initiative will inform them about therapeutic options for sHPT, and provide forums to critically analyze the latest information with leaders in the field.
After reviewing this case, participants should be able to:
- Identify common features associated with the representative chronic kidney disease case presented herein, which will enhance patient diagnostic and treatment approaches
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The France Foundation designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: July 2007
Expiration date: July 31, 2008
Method of Participation
This activity, which consists of an interactive case presentation, should take approximately 1 hour to complete. The participant should complete the activity in the order listed below:
- Read the objectives and other introductory information contained herein
- Submit your answers online
- Complete the registration information, and answer the evaluation questions on the CME Attestation/Evaluation
- Participants who answer all case questions and complete the CME Attestation and Evaluation Form will be issued a CME certificate within one month of submission to The France Foundation. Instructions for submission are found on the CME Attestation/Evaluation Form.
If you have any questions, please contact:
The France Foundation
230 Shore Road, Suite 202
Old Lyme, Connecticut 06371
Telephone: (866) 856-1998
Fax: (860) 434-5390